Logo image of SRAD

SPORTRADAR GROUP AG-A (SRAD) Stock Fundamental Analysis

NASDAQ:SRAD - Nasdaq - CH1134239669 - Common Stock - Currency: USD

28.23  +0.41 (+1.47%)

After market: 28.13 -0.1 (-0.35%)

Fundamental Rating

6

SRAD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. While SRAD has a great health rating, its profitability is only average at the moment. SRAD is valued quite expensive, but it does show an excellent growth. This makes SRAD very considerable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

SRAD had positive earnings in the past year.
In the past year SRAD had a positive cash flow from operations.
Each year in the past 5 years SRAD has been profitable.
SRAD had a positive operating cash flow in each of the past 5 years.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.32%, SRAD is in line with its industry, outperforming 51.88% of the companies in the same industry.
SRAD has a Return On Equity of 6.05%. This is in the better half of the industry: SRAD outperforms 62.41% of its industry peers.
SRAD's Return On Invested Capital of 4.33% is in line compared to the rest of the industry. SRAD outperforms 43.61% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SRAD is significantly below the industry average of 13.81%.
The last Return On Invested Capital (4.33%) for SRAD is above the 3 year average (3.32%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.32%
ROE 6.05%
ROIC 4.33%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

SRAD has a Profit Margin (5.12%) which is comparable to the rest of the industry.
SRAD's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 10.79%, SRAD is in line with its industry, outperforming 55.64% of the companies in the same industry.
SRAD's Operating Margin has been stable in the last couple of years.
SRAD has a better Gross Margin (73.07%) than 89.47% of its industry peers.
SRAD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.79%
PM (TTM) 5.12%
GM 73.07%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRAD is destroying value.
Compared to 1 year ago, SRAD has more shares outstanding
SRAD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SRAD has been reduced compared to a year ago.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

SRAD has an Altman-Z score of 3.57. This indicates that SRAD is financially healthy and has little risk of bankruptcy at the moment.
SRAD has a Altman-Z score of 3.57. This is in the better half of the industry: SRAD outperforms 78.20% of its industry peers.
SRAD has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.33, SRAD belongs to the best of the industry, outperforming 92.48% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that SRAD is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.04, SRAD belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.33
Altman-Z 3.57
ROIC/WACC0.78
WACC5.53%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

SRAD has a Current Ratio of 1.35. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SRAD (1.35) is better than 69.17% of its industry peers.
A Quick Ratio of 1.35 indicates that SRAD should not have too much problems paying its short term obligations.
SRAD has a better Quick ratio (1.35) than 72.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

9

3. Growth

3.1 Past

SRAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.23%, which is quite impressive.
SRAD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.84% yearly.
Looking at the last year, SRAD shows a very strong growth in Revenue. The Revenue has grown by 23.08%.
The Revenue has been growing by 23.81% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)69.23%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%4073.68%
Revenue 1Y (TTM)23.08%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%17.05%

3.2 Future

The Earnings Per Share is expected to grow by 66.45% on average over the next years. This is a very strong growth
Based on estimates for the next years, SRAD will show a quite strong growth in Revenue. The Revenue will grow by 12.65% on average per year.
EPS Next Y190.66%
EPS Next 2Y103.13%
EPS Next 3Y80.36%
EPS Next 5Y66.45%
Revenue Next Year16.77%
Revenue Next 2Y15.99%
Revenue Next 3Y15.48%
Revenue Next 5Y12.65%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 108.58, the valuation of SRAD can be described as expensive.
Based on the Price/Earnings ratio, SRAD is valued a bit more expensive than the industry average as 60.15% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.45, SRAD is valued quite expensively.
SRAD is valuated quite expensively with a Price/Forward Earnings ratio of 52.79.
Based on the Price/Forward Earnings ratio, SRAD is valued a bit more expensive than the industry average as 62.41% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, SRAD is valued quite expensively.
Industry RankSector Rank
PE 108.58
Fwd PE 52.79
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRAD indicates a slightly more expensive valuation: SRAD is more expensive than 60.15% of the companies listed in the same industry.
SRAD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 45.53
EV/EBITDA 16.32
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SRAD may justify a higher PE ratio.
SRAD's earnings are expected to grow with 80.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)4.97
EPS Next 2Y103.13%
EPS Next 3Y80.36%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SRAD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (7/3/2025, 8:10:32 PM)

After market: 28.13 -0.1 (-0.35%)

28.23

+0.41 (+1.47%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)N/A N/A
Inst Owners79.07%
Inst Owner Change2.14%
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap8.44B
Analysts83.64
Price Target27.42 (-2.87%)
Short Float %2.58%
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.63%
Min EPS beat(2)-100%
Max EPS beat(2)141.26%
EPS beat(4)2
Avg EPS beat(4)54.91%
Min EPS beat(4)-100%
Max EPS beat(4)278.4%
EPS beat(8)3
Avg EPS beat(8)13.27%
EPS beat(12)5
Avg EPS beat(12)-16.74%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.98%
Min Revenue beat(2)-0.42%
Max Revenue beat(2)2.39%
Revenue beat(4)3
Avg Revenue beat(4)2.56%
Min Revenue beat(4)-0.42%
Max Revenue beat(4)4.89%
Revenue beat(8)4
Avg Revenue beat(8)0.37%
Revenue beat(12)7
Avg Revenue beat(12)0.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.53%
PT rev (3m)20.71%
EPS NQ rev (1m)25.06%
EPS NQ rev (3m)-12.96%
EPS NY rev (1m)8.97%
EPS NY rev (3m)18.65%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)-0.9%
Revenue NY rev (1m)-0.99%
Revenue NY rev (3m)1.96%
Valuation
Industry RankSector Rank
PE 108.58
Fwd PE 52.79
P/S 6.22
P/FCF 45.53
P/OCF 18.46
P/B 7.35
P/tB N/A
EV/EBITDA 16.32
EPS(TTM)0.26
EY0.92%
EPS(NY)0.53
Fwd EY1.89%
FCF(TTM)0.62
FCFY2.2%
OCF(TTM)1.53
OCFY5.42%
SpS4.54
BVpS3.84
TBVpS-3.41
PEG (NY)0.57
PEG (5Y)4.97
Profitability
Industry RankSector Rank
ROA 2.32%
ROE 6.05%
ROCE 5.9%
ROIC 4.33%
ROICexc 5.22%
ROICexgc N/A
OM 10.79%
PM (TTM) 5.12%
GM 73.07%
FCFM 13.66%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
ROICexc(3y)4.06%
ROICexc(5y)5.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.52%
ROCE(5y)4.82%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y7.36%
ROICexc growth 5Y-3.96%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.33
Debt/EBITDA 0.1
Cap/Depr 77.98%
Cap/Sales 20.03%
Interest Coverage 1.57
Cash Conversion 92.36%
Profit Quality 266.99%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 3.57
F-Score7
WACC5.53%
ROIC/WACC0.78
Cap/Depr(3y)86.86%
Cap/Depr(5y)86.55%
Cap/Sales(3y)21.89%
Cap/Sales(5y)22.44%
Profit Quality(3y)195.32%
Profit Quality(5y)194.81%
High Growth Momentum
Growth
EPS 1Y (TTM)69.23%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%4073.68%
EPS Next Y190.66%
EPS Next 2Y103.13%
EPS Next 3Y80.36%
EPS Next 5Y66.45%
Revenue 1Y (TTM)23.08%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%17.05%
Revenue Next Year16.77%
Revenue Next 2Y15.99%
Revenue Next 3Y15.48%
Revenue Next 5Y12.65%
EBIT growth 1Y32.84%
EBIT growth 3Y36.08%
EBIT growth 5Y22.83%
EBIT Next Year117.47%
EBIT Next 3Y51.41%
EBIT Next 5Y36.1%
FCF growth 1Y877.26%
FCF growth 3Y347.38%
FCF growth 5Y21.32%
OCF growth 1Y111.14%
OCF growth 3Y38.73%
OCF growth 5Y19.31%